US and California award millions for psychedelic research on veteran PTSD

The federal government will spend up to $4.9 million preparing for clinical trials of ibogaine as a potential treatment for veterans with PTSD, though the awards will not fund patient treatment or human-subject research. The effort follows President Donald Trump’s allocation of $50 million for ibogaine research earlier this year. Separately, California is offering up to $4 million over three to four years for research into psychedelic treatments tailored to veterans, with projects expected to involve veterans directly and explore ways to improve health outcomes and reduce disparities.